In situ development of an artificial intelligence (AI) model for early detection of adverse drug reactions (ADRs) to ensure drug safety

In situ development of an artificial intelligence (AI) model for early detection of adverse drug reactions (ADRs) to ensure drug safety

Pharmacovigilance is a vital component of public health systems, aiming to ensure the safe use of medicinal products. In this study, an artificial intelligence (AI)-based model was developed using TensorFlow to predict the likelihood of adverse drug reactions (ADRs) based on molecular structure and...

Full description

Saved in:
Bibliographic Details
Main Authors: Veselina Ruseva, Stanimir Dobrev, Violeta Getova-Kolarova, Anna Peneva, Ilko Getov, Maria Dimitrova, Valentina Petkova
Format: Article
Language:English
Published: Pensoft Publishers 2025-07-01
Series:Pharmacia
Online Access:https://pharmacia.pensoft.net/article/160997/download/pdf/
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items